These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2158940)

  • 1. Prognostic factors for malignant mixed müllerian tumors of the uterus.
    Schweizer W; Demopoulos R; Beller U; Dubin N
    Int J Gynecol Pathol; 1990; 9(2):129-36. PubMed ID: 2158940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors in malignant mesodermal (mullerian) mixed tumors of the uterus.
    Macasaet MA; Waxman M; Fruchter RG; Boyce J; Hong P; Nicastri AD; Remy JC
    Gynecol Oncol; 1985 Jan; 20(1):32-42. PubMed ID: 2981189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant mixed müllerian tumors of the uterus. A clinicopathologic assessment of 34 cases.
    Barwick KW; LiVolsi VA
    Am J Surg Pathol; 1979 Apr; 3(2):125-35. PubMed ID: 231382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic analysis of uterine malignant mixed müllerian tumors.
    Nielsen SN; Podratz KC; Scheithauer BW; O'Brien PC
    Gynecol Oncol; 1989 Sep; 34(3):372-8. PubMed ID: 2548936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed müllerian tumors of the uterus: a clinicopathologic study.
    Dinh TV; Slavin RE; Bhagavan BS; Hannigan EV; Tiamson EM; Yandell RB
    Obstet Gynecol; 1989 Sep; 74(3 Pt 1):388-92. PubMed ID: 2548134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostically relevant factors in malignant mixed Müllerian tumor].
    Marth C; Koza A; Müller-Holzner E; Hetzel H; Fuith LC; Dapunt O
    Geburtshilfe Frauenheilkd; 1990 Aug; 50(8):605-9. PubMed ID: 2170227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of malignant, mixed mesodermal tumors of the uterus.
    Podczaski ES; Woomert CA; Stevens CW; Manetta A; Larson JE; Zaino RJ; Mortel R
    Gynecol Oncol; 1989 Feb; 32(2):240-4. PubMed ID: 2536000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal cytology in malignant mixed müllerian tumors of the uterus.
    Kanbour AI; Buchsbaum HJ; Hall A; Kanbour AI
    Gynecol Oncol; 1989 Apr; 33(1):91-5. PubMed ID: 2539314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant Mullerian mixed tumors of the uterus: a study of 21 cases.
    King ME; Kramer EE
    Cancer; 1980 Jan; 45(1):188-90. PubMed ID: 6243241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphologic prognostic factors of malignant mixed müllerian tumor of the uterus: a clinicopathologic study of 58 cases.
    Gagné E; Têtu B; Blondeau L; Raymond PE; Blais R
    Mod Pathol; 1989 Sep; 2(5):433-8. PubMed ID: 2554278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is vascular and lymphatic space invasion a main prognostic factor in uterine neoplasms with a sarcomatous component? A retrospective study of prognostic factors of 60 patients stratified by stages.
    Rovirosa A; Ascaso C; Ordi J; Abellana R; Arenas M; Lejarcegui JA; Pahisa J; Puig-Tintoré LM; Mellado B; Armenteros B; Iglesias X; Biete A
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1320-9. PubMed ID: 11955745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical-pathologic study of mixed müllerian tumors of the uterus over a 16-year period--the Medical College of Georgia experience.
    Gallup DG; Gable DS; Talledo OE; Otken LB
    Am J Obstet Gynecol; 1989 Sep; 161(3):533-8; discussion 538-9. PubMed ID: 2551168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed Mullerian tumors of the uterus: clinical and pathologic correlations.
    Lotocki R; Rosenshein NB; Grumbine F; Dillon M; Parmley T; Woodruff JD
    Int J Gynaecol Obstet; 1982 Jun; 20(3):237-43. PubMed ID: 6127253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant mixed mullerian tumors of the uterus. A clinicopathologic study of 9 patients.
    Ruffolo EH; Metts NB; Sanders HL
    Obstet Gynecol; 1969 Apr; 33(4):544-52. PubMed ID: 4304789
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic value of peritoneal washings in patients with malignant mixed müllerian tumors of the uterus.
    Geszler G; Szpak CA; Harris RE; Creasman WT; Barter JF; Johnston WW
    Am J Obstet Gynecol; 1986 Jul; 155(1):83-9. PubMed ID: 3014883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed müllerian tumours of the uterus--prognostic factors: a clinical and histopathologic study of 147 cases.
    Larson B; Silfverswärd C; Nilsson B; Pettersson F
    Radiother Oncol; 1990 Feb; 17(2):123-32. PubMed ID: 2157241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant mixed Müllerian tumors of the uterus.
    Spanos WJ; Wharton JT; Gomez L; Fletcher GH; Oswald MJ
    Cancer; 1984 Jan; 53(2):311-6. PubMed ID: 6197155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic parameters for survival of patients with malignant mesenchymal tumors of the uterus.
    Nola M; Babić D; Ilić J; Marusić M; Uzarević B; Petrovecki M; Sabioncello A; Kovac D; Jukić S
    Cancer; 1996 Dec; 78(12):2543-50. PubMed ID: 8952563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic features of sarcomas and mixed tumors of the endometrium.
    Peters WA; Kumar NB; Fleming WP; Morley GW
    Obstet Gynecol; 1984 Apr; 63(4):550-6. PubMed ID: 6322081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of a sarcomatous component outside the ovary is an adverse prognostic factor for primary ovarian malignant mixed mesodermal/mullerian tumors: a clinicopathologic study of 47 cases.
    Kunkel J; Peng Y; Tao Y; Krigman H; Cao D
    Am J Surg Pathol; 2012 Jun; 36(6):831-7. PubMed ID: 22588065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.